<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://valueaddvc.com/pulse/anthropic-ipo-oversubscribed-1-5t-valuation-pricing-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-11T17:00:09Z</news:publication_date>
      <news:title>Anthropic IPO Is Multiple Times Oversubscribed | Bankers Eye $1.5T</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/oura-counsel-health-625m-acquisition-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-11T17:00:09Z</news:publication_date>
      <news:title>Oura Buys AI Doctor Startup Counsel Health For $625M | Revenue Up 153%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/openai-10b-q3-revenue-10-9b-operating-loss-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-11T14:33:43Z</news:publication_date>
      <news:title>OpenAI Hits $10B Quarterly Revenue | Operating Loss Widens To $10.9B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/anthropic-ipo-ant-nasdaq-70-78-price-range-88b-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-11T10:08:01Z</news:publication_date>
      <news:title>Anthropic Sets $70-$78 IPO Range, Seeking Up To $88.5B With Placement</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/path-robotics-2-45b-valuation-300m-series-e-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T16:28:38Z</news:publication_date>
      <news:title>Path Robotics Quadruples To $2.45B In $300M Series E, Georgian Leads</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/startups-repricing-3x-valuations-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:30Z</news:publication_date>
      <news:title>Why Startups Are Repricing So Fast This Cycle</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/delix-therapeutics-100m-series-c-depression-drug-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:30Z</news:publication_date>
      <news:title>Delix Therapeutics Raises $100M Series C For Depression Drug Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/nominal-triples-3b-valuation-240m-series-c-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:30Z</news:publication_date>
      <news:title>Nominal Triples To $3B In 8 Months | $240M Series C, Lightspeed Leads</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/series-a-funding-42b-2026-crunchbase</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T21:26:03Z</news:publication_date>
      <news:title>Series A Funding Hits $42B In 2026, Up 60% Per Crunchbase</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/sand-ai-200m-unicorn-kling-rival-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T16:28:38Z</news:publication_date>
      <news:title>Sand.ai Hits Unicorn Status With $200M Round, Rivals Kling</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/anthropic-claude-fable-mythos-80-percent-cheaper-openai-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:30Z</news:publication_date>
      <news:title>Anthropic Undercuts OpenAI By Up To 80% With New Claude Models</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/coreweave-q3-earnings-3-66b-revenue-132b-backlog-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-11T14:33:43Z</news:publication_date>
      <news:title>CoreWeave Revenue Jumps 168% To $3.66B | Backlog Hits $132.5B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/proximal-ventures-27-5m-debut-fund-ai-drug-development-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-11T10:08:01Z</news:publication_date>
      <news:title>Proximal Ventures Raises $27.5M Debut Fund For AI Drug-Development Startups</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/nvidia-4-3-trillion-huang-securities-suit-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:30Z</news:publication_date>
      <news:title>Nvidia's $4.3 Trillion Value At Risk As Huang Faces Securities Suit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/ai-unicorns-250-h1-2026-revenue-crunchbase</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T21:26:03Z</news:publication_date>
      <news:title>AI And Robotics Lead 195 New Unicorns In H1 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://valueaddvc.com/pulse/t-therapeutics-133m-series-b-cancer-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Value Add Pulse</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T21:26:03Z</news:publication_date>
      <news:title>T-Therapeutics Raises $133M Series B For Cancer, Autoimmune TCRs</news:title>
    </news:news>
  </url>
</urlset>